These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18054653)

  • 1. Lactoferrin in Sjögren's syndrome.
    Dogru M; Matsumoto Y; Yamamoto Y; Goto E; Saiki M; Shimazaki J; Takebayashi T; Tsubota K
    Ophthalmology; 2007 Dec; 114(12):2366-7. PubMed ID: 18054653
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients.
    Aragona P; Bucolo C; Spinella R; Giuffrida S; Ferreri G
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4474-9. PubMed ID: 16303936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, cross-over, study of oral N-acetylcysteine in Sjögren's syndrome.
    Walters MT; Rubin CE; Keightley SJ; Ward CD; Cawley MI
    Scand J Rheumatol Suppl; 1986; 61():253-8. PubMed ID: 3296153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of topical Healon tears in the management of refractory dry-eye syndrome.
    DeLuise VP; Peterson WS
    Ann Ophthalmol; 1984 Sep; 16(9):823-4. PubMed ID: 6508097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experience with the treatment of ocular changes in Sjögren's syndrome].
    Portacha L
    Klin Oczna; 1984 Nov; 86(11):485-6. PubMed ID: 6535881
    [No Abstract]   [Full Text] [Related]  

  • 6. Diadenosine polyphosphates in tears of Sjogren syndrome patients.
    Carracedo G; Peral A; Pintor J
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5452-9. PubMed ID: 20484581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sjögren's syndrome, a manifestation of vitamin B complex deficiency. Statistical study of 98 cases in 17 years].
    Altamar Ríos J
    An Otorrinolaringol Ibero Am; 1985; 12(5):443-57. PubMed ID: 4083442
    [No Abstract]   [Full Text] [Related]  

  • 8. [A method of treating conjunctivitis sicca and Sjögren's disease with a secretolytic].
    Grosse-Ruyken FJ
    Klin Monbl Augenheilkd; 1973 Apr; 162(4):540-3. PubMed ID: 4724007
    [No Abstract]   [Full Text] [Related]  

  • 9. Tear fluid analysis in primary Sjögren's syndrome.
    Markusse HM; van Haeringen NJ; Swaak AJ; Hogeweg M; de Jong PT
    Clin Exp Rheumatol; 1993; 11(2):175-8. PubMed ID: 7685257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjögren's syndrome.
    Bjerrum KB
    Acta Ophthalmol Scand; 1997 Oct; 75(5):507-11. PubMed ID: 9469545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacrimal and salivary secretion in Sjögren's syndrome: the effect of systemic treatment with bromhexine.
    Prause JU; Frost-Larsen K; Høj L; Isager H; Manthorpe R
    Acta Ophthalmol (Copenh); 1984 Jun; 62(3):489-97. PubMed ID: 6380205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of primary Sjögren's syndrome with D-penicillamine: a pilot study.
    ter Borg EJ; Haanen HC; Haas FJ; Bistervels JH; Huisman FW; Kerckhaert JA; Kallenberg CG
    Neth J Med; 2002 Nov; 60(10):402-6. PubMed ID: 12607591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin A treatment on immune reactivity and lipid peroxidation in patients with Sjögren's syndrome.
    Szöcsik K; González-Cabello R; Vien CV; Mézes M; Szongoth M; Gergely P
    Clin Rheumatol; 1988 Dec; 7(4):514-9. PubMed ID: 3246135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
    Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
    Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of prednisolone in Sjögren's syndrome].
    Potiakina NN; Mikanba ZM
    Vrach Delo; 1967 Nov; 11():123-5. PubMed ID: 5621406
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the therapy of Sjogren's syndrome using cyclophosphamide].
    Messmer E
    Dtsch Med J; 1969 Jun; 20(11):383-4. PubMed ID: 5800679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pilocarpus in Sjogren's syndrome].
    Drøsdal HH
    Tidsskr Nor Laegeforen; 2003 Jan; 123(1):82-3. PubMed ID: 12600163
    [No Abstract]   [Full Text] [Related]  

  • 18. Sialochemistry in evaluating bromhexine treatment of Sjögren's syndrome.
    Nahir AM; Aryeh HB; Szargel R; Scharf Y; Gutman D; Blaustein Y; Scharf Y
    Br Med J; 1979 Oct; 2(6194):833. PubMed ID: 509119
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial of Sjögren's syndrome treatment with arechin (Resochin)].
    Chlebowski J; Propkopczuk J
    Pol Tyg Lek; 1966 Jun; 21(26):997-8. PubMed ID: 5954399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interest of prednisolone therapy in Sjögren's syndrome (author's transl)].
    Thomas M; Charpentier G; Hellenis P
    Therapie; 1981; 36(6):677-81. PubMed ID: 7342356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.